Out of the patients who had normal bone marrow at baseline, 2 patients developed mild anemia, 3 patients experienced a mild decrease in white blood cell count, and 2 patients experienced a mild reduction in albumin levels after treatment. This evidence concerns the gene ALB and anemia.